Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

Study ID: NCT06795022
Start Date: 2025-03-27
End Date: 2028-07-25
Study Type

Interventional

Study Phase

Phase2

No. of Participants

304

Intervention / Treatment

AZD9793 Intravenous (IV) monotherapy

AZD9793 Subcutaneous (SC) monotherapy)

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

Study ID: NCT04776395
Start Date: 2021-11-02
End Date: 2029-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

68

Intervention / Treatment

Dexamethasone

Iberdomide Hydrochloride

Quality-of-Life Assessment

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Study ID: NCT04797767
Start Date: 2022-02-04
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

62

Intervention / Treatment

Cladribine

Cytarabine

Mitoxantrone

Recombinant Granulocyte Colony-Stimulating Factor

Venetoclax

Bone Marrow Aspiration

Bone Marrow Biopsy

Biospecimen Collection

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

Study ID: NCT05400603
Start Date: 2023-11-06
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

Ex Vivo Expanded Allogeneic γδ T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

Genetics of Appendix Cancer Study

Study ID: NCT05734430
Start Date: 2022-11-11
End Date: 2034-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

700

Intervention / Treatment

Genetic profiling

Retrospective tissue procurement

Sponsor

Andreana Holowatyj, PhD, MSCI

Source: clinicaltrials.gov

Share:
Add to list

Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers

Study ID: NCT06085716
Start Date: 2024-02-16
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

240

Intervention / Treatment

Psychoeducational Intervention

Open Label Placebo

Psychoeducational Intervention+Placebo

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

Study ID: NCT07222488
Start Date: 2025-12-01
End Date: 2029-02-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

MK-3120

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

Study ID: NCT04678427
Start Date: 2020-11-13
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

6 Minute Walk Functional Test

Behavioral Intervention

Survey Administration

Timed Get Up and Go Test

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

Study ID: NCT06241456
Start Date: 2024-01-05
End Date: 2044-05-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

351

Intervention / Treatment

FT825

Fludarabine

Cyclophosphamide

Bendamustine

Docetaxel

Cisplatin

Cetuximab

Sponsor

Fate Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management

Study ID: NCT06804395
Start Date: 2024-10-01
End Date: 2034-10-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10000

Intervention / Treatment
Sponsor

Hackensack Meridian Health

Source: clinicaltrials.gov

Share:
Add to list